Cannabis in the News, Finance, Investment Opportunities
AmeriCann Records Historic Q2 2022 Net Income and Revenue AmeriCann Inc. (ACAN), a cannabis company that develops state-of-the-art cultivation, product manufacturing and distribution facilities, announces the release of financial and operational results for its fiscal...
Cannabis in the News, CBD Stocks, Finance, Hemp, Sponsored
Investing in Hemp Stocks? See this Guide to Tackle the Market Hemp is a plant that has been used for thousands of years for clothing, food, paper and more. Hemp is also a source of CBD, among other cannabinoids, which has proven to have medicinal benefits. Not...
Cannabis in the News, Finance, Investment Opportunities, marijuana stock, Stock Talk, Technical Analysis, Trending
22nd Century Group (Nasdaq: XXII) is a leading plant biotechnology company focused on technologies that alter the level of nicotine in tobacco plants and the level of cannabinoids in hemp/cannabis plants through genetic engineering, gene editing, and modern plant...
Cannabis in the News, Featured, Finance, Innovative Industrial Properties, Investment Opportunities, marijuana stock, Stock Talk, Technical Analysis
With a 2021 IPO sending the stock soaring to 400%, Urban-Gro should definitely be on the minds of every cannabis stock investor. But is Urban-Gro stock a strong buy? Urban-Gro (Nasdaq: UGRO) supports cultivation facilities by performing design, architectural, and...
Cannabis in the News, Finance, Innovative Industrial Properties, Investment Opportunities
With YTD gains of over 50%, Innovative Industrial Properties (NYSE: IIPR) should definitely be on the minds of every cannabis stock investor. But is it too late to invest in IIPR? IIPR is a Maryland corporation focused on the acquisition, management, and ownership of...
Cannabis in the News, CBD in the News, CBD Stocks, Finance, Investment Opportunities, marijuana stock, Research, Stock Talk, Technology/Innovations, Trending
Should you buy this cannabis biotech stock CURE Pharmaceutical? CURE Pharmaceutical Holding Corp. (OTC: CURR) focuses on the development and manufacturing of drug formulation and drug delivery technologies in novel dosage forms (thin wafers and thin films). Notably,...